Once-daily dolutegravir is superior to once-daily darunavir/ritonavir in treatment-naïve HIV-1-positive individuals: 96 week results from FLAMINGO-Reference-Cited by-同舟云学术

Once-daily dolutegravir is superior to once-daily darunavir/ritonavir in treatment-naïve HIV-1-positive individuals: 96 week results from FLAMINGO

Published:2014-11 Issue: Volume:17 Page:19490
ISSN:1758-2652
Container-title:Journal of the International AIDS Society
language:en
Short-container-title:Journal of the International AIDS Society

Author:

Molina Jean-Michel,Clotet Bonaventura,van Lunzen Jan,Lazzarin Adriano,Cavassini Matthias,Henry Keith,Kulagin Valeriv,Givens Naomi,Brennan Clare,de Oliveira Carlos Fernando

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.7448/IAS.17.4.19490/fullpdf

Reference1 articles.

1. Clotet B Feinberg J van Lunzen J Once-daily dolutegravir is superior to Darunavir + ritonavir in antiretroviral naïve adults with HIV-1 Infection: 48 week results from the randomised study ING114915 Lancet http://dx.doi.org/10.1016/S0140-6736(14)60084-2

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human immunodeficiency virus/acquired immunodeficiency syndrome in the infant;Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant;2025

2. Population Pharmacokinetic Analysis of Dolutegravir in Treatment‐Experienced Adults Living with HIV‐1;The Journal of Clinical Pharmacology;2024-07-16

3. Outcomes of severely ill patients with AIDS treated with efavirenz or dolutegravir: a multicenter, observational study;Frontiers in Medicine;2024-02-28

4. Weight and Metabolic Outcomes in Naïve HIV Patients Treated with Integrase Inhibitor-Based Antiretroviral Therapy: A Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2023-05-24

5. A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection;Retrovirology;2022-10-22